Advertisement

Topics

Hep B vaccine supply issues at Merck & Co and GSK prompt UK to prioritize access

08:29 EDT 8 Aug 2017 | BioPharma-Reporter

Public Health England has reserved NHS hepatitis B vaccine stocks for people at high risk of infection, citing shortages caused by production interruptions at Merck & Co and GSK.

Original Article: Hep B vaccine supply issues at Merck & Co and GSK prompt UK to prioritize access

NEXT ARTICLE

More From BioPortfolio on "Hep B vaccine supply issues at Merck & Co and GSK prompt UK to prioritize access"

Quick Search
Advertisement
 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...